Fulminant type 1 diabetes mellitus after COVID-19 RNA-based vaccine with
elevated antibody titer for coxsackievirus B6: A case report and review
of the literature
- Hisaka Minami,
- Shinya Furukawa
, - Teruki Miyake,
- Keisho Kurokawa,
- Yasuhiro Sasaki,
- Masayuki Nakaishi,
- Kensuke Nagamatsu,
- Hiroka Yamago,
- Naozumi Shibata,
- Yoichi Hiasa,
- Bunzo Matsuura
Shinya Furukawa
Ehime University
Corresponding Author:shinya.furukawa@gmail.com
Author ProfileTeruki Miyake
Ehime Daigaku Daigakuin Igakukei Kenkyuka Igakubu
Author ProfileKeisho Kurokawa
Ehime Daigaku Daigakuin Igakukei Kenkyuka Igakubu
Author ProfileYoichi Hiasa
Ehime University Graduate School of Medicine
Author Profile05 Jan 2025Submitted to Clinical Case Reports 08 Jan 2025Submission Checks Completed
08 Jan 2025Assigned to Editor
22 Jan 2025Reviewer(s) Assigned
13 Feb 2025Review(s) Completed, Editorial Evaluation Pending
13 Feb 2025Editorial Decision: Revise Minor
25 Feb 20251st Revision Received
04 Mar 2025Submission Checks Completed
04 Mar 2025Assigned to Editor
04 Mar 2025Review(s) Completed, Editorial Evaluation Pending
04 Mar 2025Reviewer(s) Assigned
06 Mar 2025Editorial Decision: Revise Minor
07 Mar 20252nd Revision Received
